Covid-19: Gilead's remdesivir gets India nod for restricted emergency use
India's drug regulator has granted US pharma giant Gilead Sciences marketing authorisation for its anti-viral drug remdesivir for "restricted emergency use" on hospitalised Covid-19 patients in view of the crisis posed by the pandemic. The approval process for remdesivir was accelerated in view of the emergency situation and the unmet need for medicines in light of the coronavirus outbreak, a source in the know of the developments told PTI. The drug has been allowed for restricted emergency use for treatment of suspected or laboratory-confirmed cases of Covid-19 in adults and children hospitalised with severe symptoms, subject to several safeguards, the source said. Read More